Teacher Retirement System of Texas lifted its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report ...

Thrivent Financial for Lutherans reduced its stake in Ascendis Pharma A/S (NASDAQ ... endocrinology rare disease product candidates in clinical development, as well as focuses on advancing ...

The global Ayurveda sexual wellness market was valued at US$ 1.4 Billion in 2023 and is projected to expand at a CAGR of 6.6% ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

WILMINGTON, N.C. (WECT) - The Wilmington Planning Commission will discuss two different developments next Wednesday, April 2 at 6 p.m. One is a 48-unit senior housing development located at 710 N Kerr ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

The American Red Cross and Cape Fear Craft Beer Alliance hold the event to help save lives in the community by bringing breweries from the Wilmington area together to donate blood. A 500-acre wildfire ...

Like many industries, the pharmaceutical labour market has felt ... The technology wave, push for onshore manufacturing and development, anticipated breakthroughs, and record cost setting expected ...

The market’s focus is narrow, but step outside the spotlight and you’ll find where real momentum is building LONDON, United Kingdom, March 27, 2025 (EZ Newswire) -- ValueTheMarkets, a trusted ...